Business Update
AMA Insurance to offer Cignature Rx Medicare drug plan to retired physicians
Published in Law and Health Weekly, April 29th, 2006
"We are delighted AMAIAI has chosen to offer Cigna's Medicare prescription drug plans," said Terri Swanson, vice president of Cigna Senior Care. "This decision represents a strong new relationship based on a high level of trust in our Part D program."
AMA Insurance Agency, Inc., a wholly owned subsidiary of the American Medical Association, markets and/or administers insurance plans and related products to meet the needs of physicians and their families. AMAIAI...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- BD Biosciences
BD Biosciences signs agreement with Dynomics for cancer diagnostic technology - EpiCept Corporation
EpiCept settles Maxim securities litigation - Inex Pharmaceuticals Corp.
INEX receives "statement of claim" on gene therapy technology from Protiva Biotherapeutics - Isis Pharmaceuticals, Inc.
U.S. patent issued to Isis Pharmaceuticals for antisense drugs with modified sugars - Legal Issues
Advocates for patients' rights warn about restrictive post-Schiavo legislation - Market Analysis
Aging population provides new business opportunities for geriatric drug market - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
